M&A: Page 16


  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Zimmer puts up $250M in surgical device deal, Boston Scientific nets $800M in BTG pharma sell-off

    The pandemic hasn't stopped M&A in the medtech industry, with Zimmer Biomet adding to its sternal closure device lineup via A&E Medical and Boston Scientific streamlining business with a sale to specialty pharma group SERB.

    By Dec. 1, 2020
  • Healthcare deals in Q4 predicted to fall from record-setting Q3: report

    Market research firm CB Insights believes the drop will carry over into the digital health sector too, an area that's seen historic investor interest in 2020 amid the coronavirus pandemic.

    By Rebecca Pifer • Nov. 25, 2020
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer reports record robot installs, ASC-inspired M&A

    While the company benefited from a rebound in elective procedures, execs warned investors the recovery slowed as the third quarter drew to a close.

    By Nov. 6, 2020
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Stryker closes Wright Medical acquisition after year-long wait

    The Kalamazoo, Michigan-based medtech highlighted the shoulder, elbow, wrist, hand, foot and ankle devices it's gained, along with preoperative planning technology, now that the deal is final.

    By Maria Rachal • Updated Nov. 11, 2020
  • Illumina defends Grail valuation amid much cheaper Exact-Thrive deal

    The biotech defended its $8 billion purchase price against Exact Sciences' $2.15 billion cancer screening takeout agreement announced this week, arguing Grail has more data and is likely to be first to market.

    By Oct. 30, 2020
  • Ai Biomed's PTEye device
    Image attribution tooltip
    Permission granted by Medtronic/Beth Richman
    Image attribution tooltip

    Medtronic acquires thyroid surgery tech in 7th tuck-in deal of 2020

    An addition to the medtech's pandemic-battered ENT business, Ai Biomed's PTeye system won De Novo authorization from FDA in 2018 for its ability to help surgeons spare important calcium-regulating tissue during procedures.

    By Maria Rachal • Oct. 29, 2020
  • Teleflex lines up $525M to buy hemostat specialist Z-Medica

    The medtech predicts the trauma surgery and emergency medicine-focused products will begin adding up to $70 million in revenue next year, providing growth drivers outside its key interventional urology segment.

    By Maria Rachal • Oct. 29, 2020
  • Smith & Nephew lays path to 10% growth for acquired Integra assets

    The medtech is moving deeper into the extremity orthopaedics turf fought over by the likes of Zimmer Biomet and Stryker acquisition target Wright Medical.

    By Oct. 29, 2020
  • Exact Sciences/Thrive Earlier Detection
    Image attribution tooltip
    Permission granted by Exact Sciences/Katie Boyce
    Image attribution tooltip

    Exact Sciences stock jumps on cancer detection deals for Thrive, Base Genomics

    The cancer diagnostics company is aiming to bolster its technology pipeline weeks after Illumina put up $8 billion to acquire liquid biopsy developer Grail.

    By , Maria Rachal • Updated Oct. 27, 2020
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Stryker buyout of Wright poised to pass 1-year mark without closing

    CEO Kevin Lobo said last month the $5.4 billion buyout, which has faced antitrust hurdles, was on track to be finalized in early October.  

    By Maria Rachal • Oct. 26, 2020
  • Steris inks $850M deal for Key Surgical adds to medtech M&A wave

    CEO Walter Rosebrough gave a nod to current low interest rates but said Steris had been looking at this potential transaction "for years, not months."

    By Oct. 7, 2020
  • Analysts predict Zimmer Biomet M&A in 2021 to speed growth

    The medtech is likely to initially target private orthopaedic companies worth up to $300 million, Needham analysts specified. The spine and dental businesses, meanwhile, could be on the chopping block.

    By Oct. 7, 2020
  • M&A on horizon as deep-pocketed medtechs eye distressed assets: EY

    The combination of smaller companies questioning their pandemic survival and larger companies with considerable capital may spark a buying surge, the consultancy said in its annual medtech report.

    By Oct. 6, 2020
  • Avenu Ellipsys System Catheter
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic to expand dialysis access position with Avenu Medical buyout

    The deal is the second tuck-in acquisition this year for the medtech's peripheral vascular business and the company's sixth overall, following additions to insulin delivery, surgery and spinal cord stimulation offerings.

    By Maria Rachal • Updated Sept. 30, 2020
  • COVID-19 spurred a medtech M&A boom this summer. Will it last?

    Siemens Healthineers' CEO was rebuffed by his counterpart at Varian in January. But come May, the impact of coronavirus began to become clear. 

    By Sept. 30, 2020
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Smith & Nephew inks $240M deal to buy orthopaedic assets from Integra

    The U.K.-based medtech will gain control of a portfolio of shoulder replacement products and other devices that generated revenues of $90 million last year.

    By Sept. 29, 2020
  • Illumina inks $8B Grail buyout for liquid biopsy market. Investors are not sold.

    Shares in Illumina, which formed cancer detection startup Grail in 2016, fell as analysts questioned whether the cash-and-stock deal plays to its strengths.

    By , Sept. 21, 2020
  • Qiagen
    Image attribution tooltip
    Courtesy of Qiagen
    Image attribution tooltip

    Qiagen completes takeover of PCR automation player NeuMoDx for $248M

    The still-independent Dutch molecular diagnostics company said NeuMoDx devices process test results three times as fast as some rival systems.

    By Sept. 18, 2020
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Intersect ENT strikes €60 Fiagon buyout to expand in balloon sinuplasty

    The takeover of the German electromagnetic surgical navigation specialist comes two months after a report that Medtronic moved to acquire Intersect.

    By Sept. 16, 2020
  • Stryker reaches agreement with Colfax for Wright Medical deal divestitures

    The medtech disclosed Thursday the orthopaedics competitor's DJO Global subsidiary agreed to acquire its ankle and finger joint replacement businesses to shore up U.S. and U.K. antitrust concerns.

    By Maria Rachal • Updated Oct. 16, 2020
  • Image attribution tooltip
    Photo courtesy of Stryker
    Image attribution tooltip

    Stryker stretches Wright Medical share offer into Q4

    As the medtech makes the fifth offer extension since the $4 billion acquisition was announced last November, the company is approaching the latest time it said the deal would close.

    By Updated Sept. 29, 2020
  • Philips pens $275M Intact Vascular deal to acquire implant

    The buy adds the first FDA-approved vascular implant for below-the-knee interventions to the Dutch conglomerate's portfolio.

    By Aug. 28, 2020
  • Hologic inks $80M Acessa buyout to expand women's health business

    The cash acquisition, plus contingent payments based on future revenue growth, will add a treatment for benign uterine fibroid to the medtech's portfolio.

    By Aug. 26, 2020
  • Digital Diagnostics
    Image attribution tooltip
    Courtesy of Digital Diagnostics
    Image attribution tooltip

    IDx rebrands, buys 3Derm to expand automated AI portfolio

    The takeover gives the company, now known as Digital Diagnostics, control of two breakthrough device-designated autonomous artificial intelligence systems.

    By Aug. 20, 2020
  • Image attribution tooltip
    Michelle Rock/MedTech Dive
    Image attribution tooltip

    Medtronic seeks leg up in lagging pen market with Companion Medical buy

    As Dexcom and Abbott grow share in the continuous glucose monitoring market and Insulet and Tandem forge on with interoperable insulin pump systems, Medtronic is hoping to jump ahead with a connected pen.

    By Maria Rachal • Aug. 17, 2020